Max Kepler, one of the Philadelphia Phillies' disappointing free agent signings last offseason, had a 2025 campaign to forget. He's having an offseason to forget as well. On Friday, MLB announced that the former Phillies outfielder, who's currently a free agent, received an 80-game suspension for testing positive for the performance-enhancing substance Epitrenbolone.
The news must come as a massive surprise to Phillies fans. We're still picking up our collective jaws over here after having watched Kepler stumble his way through his lone season in Philadelphia. Signed for $10 million, the Phillies were convinced that Kepler would bounce back from a down 2024 season.